{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:28:55Z","timestamp":1787020135731,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Haemodialysis patients have a high mortality rate. Part of this can be attributed to vascular access complications. Large retrospective studies have shown a higher mortality in patients dialysed with a catheter, which is mostly ascribed to infectious complications. Since we observe very little infectious complications in our haemodialysis patients, the aim of our study was to assess if we could still detect a difference in survival according to vascular access type.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients that started chronic haemodialysis treatment between 1\/1\/2007 and 31\/12\/2016 at the \u2018Universitair Ziekenhuis Brussel\u2019 were retrospectively studied. The time to death was studied as a function of the two main vascular access types using survival analysis, considering the type of vascular access at the initiation of dialysis or as time varying, and accounting for the available baseline characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 374 patients 309 (82.6%) initiated haemodialysis with a catheter, while 65 patients initiated with an arteriovenous access. Vascular access type during follow-up did not change in 74% of all patients. A Kaplan Meier plot did not suggest a survival dependent on the vascular access type at start. An extended cox proportional hazard analysis showed that vascular access type was not independently correlated with mortality. However, age, history of congestive heart failure and active cancer at initiation of dialysis were independently associated with mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this retrospective cohort study, haemodialysis vascular access type was not independently correlated with patient survival, even after taking into account change of vascular access over time.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-020-01889-4","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T04:02:47Z","timestamp":1592452967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Vascular access type and mortality in haemodialysis: a retrospective cohort study"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5588-5059","authenticated-orcid":false,"given":"Dieter","family":"De Clerck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Bonkain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Cools","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6401-1580","authenticated-orcid":false,"given":"Patricia","family":"Van der Niepen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,18]]},"reference":[{"key":"1889_CR1","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/ckj\/sfx149","volume":"11","author":"A Kramer","year":"2018","unstructured":"Kramer A, Pippias M, Noordzij M, et al. The European renal association - European Dialysis and transplant association (ERA-EDTA) registry annual report 2015: a summary. Clin Kidney J. 2018;11:108\u201322.","journal-title":"Clin Kidney J"},{"key":"1889_CR2","unstructured":"USRDS Annual Data Report 2018 Volume 2. Figure 5.4 Unadjusted percentages of deaths in 2015 by cause, with and without missing data, by modality among dialysis patients and transplant patients. \"Last accessed 13\/08\/2019\". at https:\/\/www.usrds.org\/2018\/view\/img_v2_05.html#Figure_5_4.)."},{"key":"1889_CR3","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.2215\/CJN.01690213","volume":"8","author":"CE Lok","year":"2013","unstructured":"Lok CE, Foley R. Vascular access morbidity and mortality: trends of the last decade. Clin J Am Soc Nephrol. 2013;8:1213\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1889_CR4","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1681\/ASN.2013091009","volume":"25","author":"S Aslam","year":"2014","unstructured":"Aslam S, Vaida F, Ritter M, Mehta RL. Systematic review and meta-analysis on management of hemodialysis catheter-related bacteremia. J Am Soc Nephrol. 2014;25:2927\u201341.","journal-title":"J Am Soc Nephrol"},{"key":"1889_CR5","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1053\/j.ajkd.2014.07.010","volume":"64","author":"T Banerjee","year":"2014","unstructured":"Banerjee T, Kim SJ, Astor B, Shafi T, Coresh J, Powe NR. Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the choices for healthy outcomes in caring for end-stage renal disease (CHOICE) study. Am J Kidney Dis. 2014;64:954\u201361.","journal-title":"Am J Kidney Dis"},{"key":"1889_CR6","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/sdi.12459","volume":"29","author":"NN Rao","year":"2016","unstructured":"Rao NN, Dundon BK, Worthley MI, Faull RJ. The impact of Arteriovenous fistulae for hemodialysis on the cardiovascular system. Semin Dial. 2016;29:214\u201321.","journal-title":"Semin Dial"},{"issue":"Suppl 2","key":"1889_CR7","first-page":"ii88","volume":"22","author":"J Tordoir","year":"2007","unstructured":"Tordoir J, Canaud B, Haage P, et al. EBPG on Vascular Access. Nephrol Dial Transplant. 2007;22(Suppl 2):ii88\u2013117.","journal-title":"Nephrol Dial Transplant"},{"key":"1889_CR8","volume-title":"Should a fistula first policy be revisited in elderly haemodialysis patients? Nephrol dial transplant","author":"C Lomonte","year":"2018","unstructured":"Lomonte C, Basile C, Mitra S, et al. Should a fistula first policy be revisited in elderly haemodialysis patients? Nephrol dial transplant 2018."},{"key":"1889_CR9","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1093\/ndt\/gfu253","volume":"29","author":"M Noordzij","year":"2014","unstructured":"Noordzij M, Jager KJ, van der Veer SN, et al. Use of vascular access for haemodialysis in Europe: a report from the ERA-EDTA registry. Nephrol Dial Transplant. 2014;29:1956\u201364.","journal-title":"Nephrol Dial Transplant"},{"key":"1889_CR10","doi-asserted-by":"crossref","unstructured":"El-Hennawy AS, Frolova E, Romney WA. Sodium bicarbonate catheter lock solution reduces hemodialysis catheter loss due to catheter-related thrombosis and blood stream infection: an open-label clinical trial. Nephrol Dial Transplant. 2019.","DOI":"10.1093\/ndt\/gfy388"},{"key":"1889_CR11","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1046\/j.1523-1755.2001.00947.x","volume":"60","author":"RK Dhingra","year":"2001","unstructured":"Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK. Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int. 2001;60:1443\u201351.","journal-title":"Kidney Int"},{"key":"1889_CR12","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1046\/j.1523-1755.2002.00460.x","volume":"62","author":"S Pastan","year":"2002","unstructured":"Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int. 2002;62:620\u20136.","journal-title":"Kidney Int"},{"key":"1889_CR13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/01.ASN.0000109668.05157.05","volume":"15","author":"KR Polkinghorne","year":"2004","unstructured":"Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol. 2004;15:477\u201386.","journal-title":"J Am Soc Nephrol"},{"key":"1889_CR14","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.ajkd.2003.07.004","volume":"42","author":"JL Xue","year":"2003","unstructured":"Xue JL, Dahl D, Ebben JP, Collins AJ. The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. Am J Kidney Dis. 2003;42:1013\u20139.","journal-title":"Am J Kidney Dis"},{"key":"1889_CR15","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1681\/ASN.2004090748","volume":"16","author":"BC Astor","year":"2005","unstructured":"Astor BC, Eustace JA, Powe NR, et al. Type of vascular access and survival among incident hemodialysis patients: the choices for healthy outcomes in caring for ESRD (CHOICE) study. J Am Soc Nephrol. 2005;16:1449\u201355.","journal-title":"J Am Soc Nephrol"},{"key":"1889_CR16","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1053\/j.ajkd.2005.11.023","volume":"47","author":"M Allon","year":"2006","unstructured":"Allon M, Daugirdas J, Depner TA, Greene T, Ornt D, Schwab SJ. Effect of change in vascular access on patient mortality in hemodialysis patients. Am J Kidney Dis. 2006;47:469\u201377.","journal-title":"Am J Kidney Dis"},{"key":"1889_CR17","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.2215\/CJN.01240308","volume":"3","author":"LM Moist","year":"2008","unstructured":"Moist LM, Trpeski L, Na Y, Lok CE. Increased hemodialysis catheter use in Canada and associated mortality risk: data from the Canadian organ replacement registry 2001-2004. Clin J Am Soc Nephrol. 2008;3:1726\u201332.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1889_CR18","first-page":"19","volume":"17","author":"BR Di Iorio","year":"2004","unstructured":"Di Iorio BR, Bellizzi V, Cillo N, et al. Vascular access for hemodialysis: the impact on morbidity and mortality. J Nephrol. 2004;17:19\u201325.","journal-title":"J Nephrol"},{"key":"1889_CR19","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1053\/j.ajkd.2008.10.043","volume":"53","author":"RL Pisoni","year":"2009","unstructured":"Pisoni RL, Arrington CJ, Albert JM, et al. Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. Am J Kidney Dis. 2009;53:475\u201391.","journal-title":"Am J Kidney Dis"},{"key":"1889_CR20","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/nep.12688","volume":"21","author":"J Kasza","year":"2016","unstructured":"Kasza J, Wolfe R, McDonald SP, Marshall MR, Polkinghorne KR. Dialysis modality, vascular access and mortality in end-stage kidney disease: a bi-national registry-based cohort study. Nephrology (Carlton). 2016;21:878\u201386.","journal-title":"Nephrology (Carlton)"},{"key":"1889_CR21","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1681\/ASN.2016010019","volume":"28","author":"RS Brown","year":"2017","unstructured":"Brown RS, Patibandla BK, Goldfarb-Rumyantzev AS. The survival benefit of \"fistula first, catheter last\" in hemodialysis is primarily due to patient factors. J Am Soc Nephrol. 2017;28:645\u201352.","journal-title":"J Am Soc Nephrol"},{"key":"1889_CR22","doi-asserted-by":"publisher","first-page":"955","DOI":"10.2215\/CJN.12181116","volume":"12","author":"P Ravani","year":"2017","unstructured":"Ravani P, Quinn R, Oliver M, et al. Examining the association between hemodialysis access type and mortality: the role of access complications. Clin J Am Soc Nephrol. 2017;12:955\u201364.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"1889_CR23","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/ndt\/gfy254","volume":"35","author":"GJ Ko","year":"2018","unstructured":"Ko GJ, Rhee CM, Obi Y, et al. Vascular access placement and mortality in elderly incident hemodialysis patients. Nephrol Dial Transplant. 2018;35(3):503.","journal-title":"Nephrol Dial Transplant"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01889-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-020-01889-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01889-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T19:13:55Z","timestamp":1623957235000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-01889-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,18]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1889"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-01889-4","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,18]]},"assertion":[{"value":"7 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the ethics committee \u2018Commissie Medische Ethiek\u2019 O.G. 0.16. Reference number 2018\/268.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"231"}}